ΨΥΧΟΛΟΓΙΑ - Έρευνα και Εφαρμογές ΤΕΥΧΟΣ 3 | Page 15

«ΨΥΧΟΛΟΓΙΑ έρευνα & εφαρμογές» Τόμος 1, Τεύχος 3, 2018 ISSN: 2623-3673
46.
https://www.genome.gov/19518344/gao-concludes-dtc-genetic-tests-mislead-
consumers/ (government accountability office)
47. http://www.pev.gr Αίτημα αναίρεσης άδειας του ΥΠΕΠΘ για "γενετικά" τεστ
στους μαθητές
48. Pharmacogenetics and Antipsychotics: Therapeutic Efficacy and Side Effects
Prediction Jian-Ping Zhang, MD, PhD and Anil K. Malhotra, MD Expert Opin Drug
Metab Toxicol. 2011 Jan; 7(1): 9–37.
49. Pharmacogenetics in Psychiatry: Are We Ready for Widespread Clinical Use?
Maria J. Arranz1,2 and Shitij Kapur2. Schizophr Bull. 2008 Nov; 34(6): 1130–1144.
50. D2 receptor genetic variation and clinical response to antipsychotic drug
treatment: a meta-analysis. Zhang JP Lencz T, Malhotra AK. Am J Psychiatry. 2010
Jul;167(7):763-72
51. Cost-effectiveness of pharmacogenetic-guided treatment: are we there yet? M
Verbelen, M E Weale, and C M Lewis Pharmacogenomics J. 2017 Oct; 17(5): 395–
402.
52.www.smchealth.org/sites/main/files/fileattachments/psychiatric_pharmacogenomi
cs_testing
53. Evidence Brief: The Comparative Effectiveness, Harms, and ... - HSR&D
https://www.hsrd.research.va.gov/.../pharmacogenomics.
54. Pharmacogenomics in the treatment of mood disorders: Strategies and
Opportunities for personalized psychiatry. Azmeraw T. AmareKlaus Oliver
SchubertBernhard T. Baune EPMA Journal September 2017, Volume 8, Issue 3, pp
211–227.
55. Molecular genetics of CYP2D6: Clinical relevance with focus on psychotropic
drugs Leif Bertilsson, Marja-Liisa Dahl, Per Dalén, and Ayman Al-Shurbaji, Br J Clin
Pharmacol. 2002 Feb; 53(2): 111–122
56. The Promise and Reality of Pharmacogenetics in Psychiatry Peter P. Zandi and
Jennifer T. Judy 1Department of Mental Health; Johns Hopkins University
Bloomberg School of Public Health, Psychiatr Clin North Am. 2010 March ; 33(1):
181–224.
57. Joseph McGraw, in Handbook of Pharmacogenomics and Stratified Medicine,
2014
58. Personalized medicine in psychiatry: problems and promises Uzoezi Ozomaro,
Claes Wahlestedt, and Charles B Nemeroff. BMC Med. 2013; 11: 132
59. Combinatorial pharmacogenomic guidance for psychiatric medications reduces
overall pharmacy costs in a 1 year prospective evaluation. Winner J, Carhart J, Altar
CA1, Goldfarb S, Allen J, Lavezzari G, Parsons K, Marshak A, Garavaglia S,
Dechairo B. Curr Med Res Opin. 2015;31(9):1633-43.